SkinHealth Systems Statistics
Total Valuation
SKIN has a market cap or net worth of $84.60 million. The enterprise value is $247.57 million.
| Market Cap | 84.60M |
| Enterprise Value | 247.57M |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SKIN has 130.14 million shares outstanding. The number of shares has increased by 2.43% in one year.
| Current Share Class | 130.14M |
| Shares Outstanding | 130.14M |
| Shares Change (YoY) | +2.43% |
| Shares Change (QoQ) | -1.37% |
| Owned by Insiders (%) | 8.63% |
| Owned by Institutions (%) | 28.69% |
| Float | 55.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 17.21 |
| PS Ratio | 0.29 |
| Forward PS | 0.29 |
| PB Ratio | 1.52 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 4.00 |
| P/OCF Ratio | 3.85 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.33, with an EV/FCF ratio of 11.71.
| EV / Earnings | n/a |
| EV / Sales | 0.85 |
| EV / EBITDA | 12.33 |
| EV / EBIT | n/a |
| EV / FCF | 11.71 |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 6.61.
| Current Ratio | 1.76 |
| Quick Ratio | 1.33 |
| Debt / Equity | 6.61 |
| Debt / EBITDA | 14.55 |
| Debt / FCF | 17.36 |
| Interest Coverage | -0.17 |
Financial Efficiency
Return on equity (ROE) is -43.89% and return on invested capital (ROIC) is -1.97%.
| Return on Equity (ROE) | -43.89% |
| Return on Assets (ROA) | -0.54% |
| Return on Invested Capital (ROIC) | -1.97% |
| Return on Capital Employed (ROCE) | -1.35% |
| Weighted Average Cost of Capital (WACC) | 6.25% |
| Revenue Per Employee | $473,158 |
| Profits Per Employee | -$46,385 |
| Employee Count | 613 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 1.84 |
Taxes
In the past 12 months, SKIN has paid $4.71 million in taxes.
| Income Tax | 4.71M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.58% in the last 52 weeks. The beta is 1.00, so SKIN's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | -70.58% |
| 50-Day Moving Average | 0.73 |
| 200-Day Moving Average | 1.03 |
| Relative Strength Index (RSI) | 46.12 |
| Average Volume (20 Days) | 481,214 |
Short Selling Information
The latest short interest is 7.59 million, so 5.84% of the outstanding shares have been sold short.
| Short Interest | 7.59M |
| Short Previous Month | 8.75M |
| Short % of Shares Out | 5.84% |
| Short % of Float | 13.63% |
| Short Ratio (days to cover) | 1.52 |
Income Statement
In the last 12 months, SKIN had revenue of $290.05 million and -$28.43 million in losses. Loss per share was -$0.22.
| Revenue | 290.05M |
| Gross Profit | 192.45M |
| Operating Income | -4.31M |
| Pretax Income | -23.73M |
| Net Income | -28.43M |
| EBITDA | 20.08M |
| EBIT | -4.31M |
| Loss Per Share | -$0.22 |
Balance Sheet
The company has $204.07 million in cash and $367.04 million in debt, with a net cash position of -$162.97 million or -$1.25 per share.
| Cash & Cash Equivalents | 204.07M |
| Total Debt | 367.04M |
| Net Cash | -162.97M |
| Net Cash Per Share | -$1.25 |
| Equity (Book Value) | 55.57M |
| Book Value Per Share | 0.43 |
| Working Capital | 127.04M |
Cash Flow
In the last 12 months, operating cash flow was $21.96 million and capital expenditures -$817,000, giving a free cash flow of $21.14 million.
| Operating Cash Flow | 21.96M |
| Capital Expenditures | -817,000 |
| Depreciation & Amortization | 24.39M |
| Net Borrowing | -20.86M |
| Free Cash Flow | 21.14M |
| FCF Per Share | $0.16 |
Margins
Gross margin is 66.35%, with operating and profit margins of -1.49% and -9.80%.
| Gross Margin | 66.35% |
| Operating Margin | -1.49% |
| Pretax Margin | -8.18% |
| Profit Margin | -9.80% |
| EBITDA Margin | 6.92% |
| EBIT Margin | -1.49% |
| FCF Margin | 7.29% |
Dividends & Yields
SKIN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.43% |
| Shareholder Yield | -2.43% |
| Earnings Yield | -33.61% |
| FCF Yield | 24.99% |
Analyst Forecast
The average price target for SKIN is $1.04, which is 59.98% higher than the current price. The consensus rating is "Hold".
| Price Target | $1.04 |
| Price Target Difference | 59.98% |
| Analyst Consensus | Hold |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 0.66% |
| EPS Growth Forecast (3Y) | -13.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SKIN has an Altman Z-Score of -0.39 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.39 |
| Piotroski F-Score | 5 |